AAD Releases Five Recommendations for Dermatology Providers
The American Academy of Dermatology (AAD) is joining the American Board of Internal Medicine (ABIM) Foundation’s Choosing Wisely campaign in November during National Healthy Skin Month. The campaign focuses on ways to facilitate conversations between physicians and patients about treatments, tests, and procedures that may be unnecessary. This enables patients to choose care that is “supported by evidence, not duplicative of other tests or procedures already received, free from harm, and truly necessary.”
The campaign consists of over 80 medical societies ranging from American Academy of Allergy, Asthma, and Immunology to Society of Vascular Medicine. In order to participate, each society contributes expert guidance on five medical tests or treatments. These topics were selected based on overuse, misuse, need for improvement, and availability of evidence-based research.
This year the AAD’s contributions to Choosing Wisely are:
1. Don’t prescribe oral antifungal therapy for suspected nail fungus without confirmation of fungal infection.
2. Don’t perform sentinel lymph node biopsy or other diagnostic tests for the evaluation of early, thin melanoma because they do not improve survival.
3. Don’t treat uncomplicated, non-melanoma skin cancer less than 1 centimeter in size on the trunk and extremities with Mohs micrographic surgery.
4. Don’t use oral antibiotics for treatment of atopic dermatitis unless there is clinical evidence of infection.
5. Don’t routinely use topical antibiotics on a surgical wound.
According to the AAD goes on to stress that, of course, at times “the items on the Choosing Wisely list will be appropriate,” but that it’s up to health care providers and their patients to have candid discussions about doing “the right thing, at the right time, for the right patient.” This information will help patients be better informed about their options in receiving care, and spark further conversations with their doctors and physician assistants.
Source: 1, 2, 3